Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization
about
Membrane lipids: where they are and how they behaveChlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular developmentAll members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activityImpaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesityRole of sphingomyelin synthase in controlling the antimicrobial activity of neutrophils against Cryptococcus neoformansSerine palmitoyltransferase (SPT) deficient mice absorb less cholesterolMacrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in miceSelective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.Myeloid cell-specific serine palmitoyltransferase subunit 2 haploinsufficiency reduces murine atherosclerosis.Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids.Pharmacologic inhibition of sphingomyelin synthase (SMS) activity reduces apolipoprotein-B secretion from hepatocytes and attenuates endotoxin-mediated macrophage inflammation.Sphingomyelin synthases regulate protein trafficking and secretionCeramide is involved in alcohol-induced neural proliferation.Reducing plasma membrane sphingomyelin increases insulin sensitivity.Sphingolipid metabolism regulates development and lifespan in Caenorhabditis elegans.Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injuryRegulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12/CXCR4 pathway.Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.Host sphingomyelin increases West Nile virus infection in vivoSuppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamageSphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogeneIntegration of cytokine biology and lipid metabolism in strokeAlcohol-induced metabolomic differences in humans.Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in miceSphingomyelin synthases regulate production of diacylglycerol at the Golgi.Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels.Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall.Remodeling of sphingolipids by plasma membrane associated enzymes.Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.Charged residues next to transmembrane regions revisited: "Positive-inside rule" is complemented by the "negative inside depletion/outside enrichment rule"Sphingomyelin Synthase 1 Regulates Neuro-2a Cell Proliferation and Cell Cycle Progression Through Modulation of p27 Expression and Akt Signaling.Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells.Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.A toxin-based probe reveals cytoplasmic exposure of Golgi sphingomyelinThe domain responsible for sphingomyelin synthase (SMS) activityTricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells.Mechanisms involved in cellular ceramide homeostasisSphingomyelin metabolism is involved in the differentiation of MDCK cells induced by environmental hypertonicity.Molecular cloning, sequence characterization, and tissue expression analysis of chicken sphingomyelin synthase 1 (SMS1).Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
P2860
Q24653084-C1D84F14-5328-4BB3-937C-89A58EEFDB11Q27349136-BBE91106-339D-46FE-BE77-44B93E0B960CQ28117543-AE6EE5A9-6589-4EF3-8C75-148052621F6BQ28281865-752C8054-2DAB-4753-81E0-05A3F1FC9A98Q28476635-721603A1-4780-4451-9722-27DF5971443BQ28510763-CF089823-3A52-40D1-8812-1D21EC0F9B20Q30490333-745A4E9D-6545-47B7-8C4E-C6AF1AD66049Q30524346-ECE3AF78-4CB2-42DF-9145-567407ED686DQ30538274-323D2437-BCC2-407C-A13F-EF68D60499AAQ33798777-6C989C91-D0CF-4A7E-B245-54EADB4DCD0EQ33916433-11D9D05A-D2BE-47B8-97D1-B66DAC81E245Q34042764-82D5F550-1025-47A1-A27B-FE41C75087FEQ34095500-70010CC1-E05C-4AFF-8735-DF1D57B33DE2Q34208250-95A98BD3-51F1-4ECB-B6A1-0EE084C07A95Q34938909-463E1C96-AC75-4821-A801-E82463132D52Q35771622-4B5B95EC-C269-40E5-A38A-1933ABB9DB7FQ36211046-92ACEE86-4D2C-483F-82DE-F5FAB7C82F54Q36239748-65D4F8CD-AC5F-4472-9F16-69FD261F1963Q36617464-455949E8-F792-4A0D-824F-CBFA807A1047Q36731419-87623D91-2938-42DC-B353-F41F454F9A15Q36744139-94F3885A-C26A-4FA2-B701-F816D7E33406Q36992077-B58030F0-D9D6-404C-91D0-932DE154D191Q37065278-264B513D-250A-4A09-AD58-BBCC8F81495FQ37391027-80C95DE2-288A-4DC2-B0FE-9C20E27A8156Q37444626-DDD5F874-5DFC-407F-BE2B-8910C33EB4CBQ37446891-BC38B1F6-BBF8-4B8B-9E33-6749287BBFB1Q37730677-26AEE285-8CFC-4610-9D53-71E2038E81A2Q37823410-E2C81B0D-8EF2-4D91-8200-E10063CD4FE7Q37958637-36AEC1CC-4221-477E-A555-83793ABE1BF1Q38664342-02434613-E5B3-4392-A965-91270ADEA174Q38969493-C615373B-D234-4292-97D4-A255ABF3B60DQ39573995-F3742DFA-4FF1-49D7-852C-DE4CBF185DB2Q41664781-DA3443E6-5685-4243-AF28-0E645C25EF76Q41893076-7D99480F-E821-4B11-B5E4-C22B274C9458Q42241468-FCCA155B-5379-432B-9A17-73107F1D5A35Q42315013-CF4DC175-6687-4EF5-AEB3-BE52E3723DEDQ42531983-07FBA0C1-DA14-4893-95E1-CDC0B5045A5AQ42695660-90D282DE-6147-4D15-BCE0-104B51C1964DQ46939215-06AC8629-8392-4234-B057-01AE3808399DQ47170906-E4B63EED-7875-4E2F-9566-D72FBAEC5537
P2860
Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@ast
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@en
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@nl
type
label
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@ast
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@en
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@nl
prefLabel
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@ast
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@en
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@nl
P2093
P2860
P1476
Inhibition of sphingomyelin sy ...... ma membrane lipid organization
@en
P2093
Dale C Duckworth
David A Peake
Guoqing Cao
Hongwen Zhou
Ming-Shang Kuo
Tiruneh K Hailemariam
Xian-Cheng Jiang
Youyan Zhang
Zhiqiang Li
P2860
P304
P356
10.1016/J.BBALIP.2007.05.007
P407
P577
2007-09-01T00:00:00Z